About Applied BioMath
Applied BioMath is a Healthcare company based in Cambridge (United States) founded in 2013, and was acquired by Certara in December 2023. Systems biology and pharmacology modeling services to aid drug discovery and development. Applied BioMath has raised $2.32 million across 10 funding rounds from investors including NIH, Certara and HHS. The company has 61 employees. Applied BioMath offers products and services including Phoenixâ„¢, Pinnacle 21, and Simcypâ„¢. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include NTxBio, Nimble Therapeutics and Enveda; 3 of its 3 listed competitors have raised funding.
Company details
Applied BioMath, applies mechanistic modeling to drug development, helps biotechnology and pharmaceutical companies answer complex, critical GoNo-go decisions in RD. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. They aim to shorten project timelines, lowers cost, and increases the likelihood of a best-in-class drug. Their service offering spans systems biology and pharmacology. Its systems biology services include pathway model development and analysis, new target discovery, biomarker discovery, and experiment design and prioritization; and systems pharmacology services include feasibility assessments for biologics and small molecule targets, analysis and differentiation of competitor compounds, predict drug properties, first in human dose projection, Phase 1 analysis, indication-specific dose projections, and identification of mechanistic covariates. The company also provides systems informatics services, including principal components analysis, partial least squares regression, cue-signal-response analysis, and Booleanfuzzy logic.
- Headquarters Cambridge, United States
- Employees 61
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website appliedbiomath.com
- Social LinkedIn X Facebook
- Acquired by Certara (Dec 2023)
Products & Services of Applied BioMath
Applied BioMath offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, and Simcyp™.
Tool for PK, PD, and toxicokinetic analysis in drug development.
Platform for data standardization and validation in clinical trials.
Simulates drug behavior in populations for PBPK modeling.
Funding Insights of Applied BioMath
Applied BioMath has successfully raised a total of $2.32M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $299.99 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.32M
- Total Rounds 10
- Last Round Grant — $299,987
- First Round $930,000
(Jan 2014)
- Investors Count 2
All 10 funding rounds of Applied BioMath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $299,987 | Grant | – | – | |
| Jun 2020 | Grant | – | – | ||
| Jun 2020 | $1.48M | Grant | – | – | |
| Feb 2020 | $25,000 | Seed | – | – | – |
| Sep 2019 | $150,000 | Grant | – | – | |
| Sep 2017 | $1.68M | Grant | – | – | |
| May 2016 | $1.5M | Grant | – | – | |
| May 2016 | $1.49M | Grant | – | – | |
| Jun 2015 | $1.36M | Seed | – | – | – |
| Jan 2014 | $930,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Applied BioMath
Applied BioMath has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, Certara and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Provider of a platform for in silico drug discovery and consulting services | 2008 | certara.com | Princeton, United States |
Investor details for Applied BioMath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Applied BioMath
28 people are tracked at Applied BioMath (4 in leadership, 8 in board & advisors, 16 in team); the tracked headcount is 61.
| Name | Role | Group |
|---|---|---|
Bruce Gomes | Executive Director of Business Development & Scientific Collaborations | Leadership |
Andrew Sutherland | Co-Founder & CFO | Leadership |
Kas Subramanian | Senior Director, Preclinical Modeling | Leadership |
Joshuaine Grant | Director, Modeling | Leadership |
Joseph Loscalzo | Scientific Advisor | Board & advisors |
Werner Meier | Scientific Advisor | Board & advisors |
Vihann Kong | Advisor | Board & advisors |
Peter Sorger | Advisor | Board & advisors |
Bruce Tidor | Scientific Advisor | Board & advisors |
Douglas A. Lauffenburger | Chair | Board & advisors |
Dhaval Shah | Scientific Advisor | Board & advisors |
Mike Yaffe | Scientific Advisor | Board & advisors |
Kavitha Parupati | Senior Software Engineer, Front End | Team |
Max Nowak | Senior Scientist | Team |
Kimiko McGirr | Senior Scientist | Team |
Saheli Sarkar | Senior Principal Scientist | Team |
Marissa Renardy | Principal Scientist | Team |
Bryan Lagos | Client Engagement Specialist | Team |
Ben Schenker | SVP, Sales & Business Development | Team |
Rachel Kiehne | Client Engagement Specialist | Team |
8 more people are available in the full profile.
Complete people profiles for Applied BioMath
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Applied BioMath
4 dated milestones of Applied BioMath across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Applied BioMath is founded.
- Funding First funding round of $930K.
- Funding Latest funding round, Grant, of $300K.
- Exit Acquired by Certara.
Competitors of Applied BioMath
Applied BioMath has 3 listed competitors in our database, 3 of them funded. They include NTxBio, Nimble Therapeutics and Enveda.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ntxbio.com | 2016 | Santa Fe, United States | $74.76M | Provider of bio informatics platform to develops biologics and therapeutics | ||
| nimbletherapeutics.com | 2019 | Madison, United States | $10M | 24 | Combinatorial chemistry services for peptide-based drug discovery are provided. | |
| enveda.com | 2019 | Boulder, United States | $845M | Provider of AI-based platform to decipher the chemistry of nature and develop new medicines |
Detailed competitors of Applied BioMath
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Applied BioMath
The website of Applied BioMath (appliedbiomath.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 90% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Applied BioMath (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Applied Biomath
Complete news archive for Applied BioMath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Applied BioMath
Applied BioMath was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Applied BioMath is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Applied BioMath is a funded company, having raised a total of $2.32M across 10 funding rounds to date. The company's 1st funding round was a Seed of $930K, raised on Jan 2014.
Applied BioMath has 61 employees.
Applied BioMath, applies mechanistic modeling to drug development, helps biotechnology and pharmaceutical companies answer complex, critical GoNo-go decisions in RD. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. They aim to shorten project timelines, lowers cost, and increases the likelihood of a best-in-class drug. Their service offering spans systems biology and pharmacology. Its systems biology services include pathway model development and analysis, new target discovery, biomarker discovery, and experiment design and prioritization; and systems pharmacology services include feasibility assessments for biologics and small molecule targets, analysis and differentiation of competitor compounds, predict drug properties, first in human dose projection, Phase 1 analysis, indication-specific dose projections, and identification of mechanistic covariates. The company also provides systems informatics services, including principal components analysis, partial least squares regression, cue-signal-response analysis, and Booleanfuzzy logic.
Applied BioMath's top competitors include NTxBio, Enveda and Nimble Therapeutics.
Applied BioMath offers Phoenixâ„¢, Pinnacle 21, and Simcypâ„¢.
Yes. Applied BioMath was acquired by Certara in December 2023.